TrialJournal of clinical pharmacology2025

Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study.

Miwa Haranaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.